Aminophosphine ligands as a privileged platform for development of antitumoral ruthenium(ii) arene complexes-Reference-Cited by-同舟云学术

Aminophosphine ligands as a privileged platform for development of antitumoral ruthenium(ii) arene complexes

Published:2017 Issue:46 Volume:46 Page:16113-16125
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Broomfield L. M.¹²³⁴,Alonso-Moreno C.⁵⁶⁷⁸⁹^ORCID,Martin E.¹²³⁴,Shafir A.¹²³⁴,Posadas I.¹⁰¹¹¹²⁴¹³,Ceña V.¹⁰¹¹¹²⁴¹³,Castro-Osma J. A.⁵⁶⁷⁸⁹^ORCID

Affiliation:

1. Institute of Chemical Research of Catalonia (ICIQ)

2. Barcelona Institute of Science and Technology

3. Tarragona

4. Spain

5. Departamento de Química Inorgánica

6. Orgánica y Bioquímica

7. Facultad de Farmacia

8. Universidad de Castilla-La Man-cha

9. 02071-Albacete

10. CIBERNED

11. Instituto de Salud Carlos III

12. Madrid

13. Unidad Asociada Neurodeath CSIC-UCLM

Abstract

The potential utility of aminophosphine ligands in both high-throughput testing and rational design of new anticancer metallodrugs.

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2017/DT/C7DT03369A

Reference80 articles.

1. Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

2. Systemic cancer therapy: achievements and challenges that lie ahead

3. Anticancer Drug Development , in Pharmaceutical Perspectives of Cancer Therapeutics , ed. Y. Lu and R. I. Mahato , Springer Science+Business Media, LLC , 2009

4. Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

5. Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of heteroscorpionate ligands as scaffolds for the generation of Ruthenium(II) metallodrugs in breast cancer therapy;Journal of Inorganic Biochemistry;2024-04

2. Synthesis, structure and biological evaluation as antibacterial agents of Ru(II)-p-cymene-aryldicyclohexylphosphine complexes;Inorganica Chimica Acta;2023-12

3. Evaluation of Heteroscorpionate Ligands as Scaffolds for the Generation of Ruthenium(Ii) Metallodrugs in Breast Cancer Therapy;2023

4. Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers;Cancers;2022-09-15

5. Design and Anticancer Properties of New Water-Soluble Ruthenium–Cyclopentadienyl Complexes;Pharmaceuticals;2022-07-14